Tamarly Intelligence
Deal · Agreement signed

CorMedix Inc. and Heron Therapeutics, Inc.

First filed 9 Nov 2026, 1 filing.

Share this pageLinkedInXEmail
The deal
Buyer
CorMedix Inc.
Target
Heron Therapeutics, Inc.
Status
Agreement signed
Region
US
Asset Purchase Agreement On November 8, 2026, CorMedix Inc., a Delaware corporation (the "Company," "CorMedix," "we," "our" and "us"), and Heron Therapeutics, Inc., a Delaware corporation (the "Seller" or "Heron"), entered into an Asset Purchase Agreement (the "Purchase Agreement"), pursuant to which the Seller has agreed to sell substantially all of its assets to the Company, other than certai...

Source: The filing (SEC Form 8-K)

Free, with no account

The rest of this page is free to read: alerts on the next filing, buyer lists, exports.

Explore for freeSign in

Research from public records, not investment advice. Tamarly holds no investment positions. By reading these pages you accept the Terms of Use; figures can be late or wrong, so check the linked source before relying on one. Terms and policies.